Abstract
Toluidine blue (TBO) is a cationic thiazine dye with an affinity for neoplastic tissues in vivo. The objective of this study was to explore the in vitro photosensitizing potential of TBO and its capacity to induce apoptosis in human leukaemic T cells. Jurkat cells were incubated with TBO for one hour followed by exposure to 11 J cm-2 of visible light from a slide projector. Cytotoxicity was assessed at 24 hours using a MTT assay. DNA fragmentation was examined at different intervals after photodynamic treatment using a DNA elution-filtration assay with [14C]- thymidine labelled cells. Caspase-3 like activation induced by photodynamic treatment was studied by measuring AC-DEVD-AMC peptide hydrolysis. The MTT assay showed a 97% decrease in optical density 24 hours following photodynamic therapy with 0.15 μg m-11 of TBO. Dark toxicity was absent under these conditions. DNA fragmentation was detected as early as 2 hours after photodynamic therapy and reached 68% at 6 hours. At higher TBO concentrations less DNA fragmentation and more dark toxicity was observed. An increase in caspase-3 like activity was also induced by photodynamic therapy with TBO. At the time of light exposure TBO was present in the endoplasmic reticulum and Golgi regions. In conclusion, TBO-based photodynamic therapy has a potent phototoxic effect and induces apoptosis in Jurkat cells.
Similar content being viewed by others
References
J. S. McCaughan, Photodynamic therapy: a review, Drugs Aging, 1999, 15, 49–68.
C. H. Sibata, V. C. Colussi, N. L. Oleinick and T. J. Kinsella, Photodynamic therapy in oncology, Expert. Opin. Pharmacother., 2001, 2, 917–927.
M. Wilson and N. Mia, Sensitization of Candida albicans to killing by low-power laser light, J. Oral. Pathol. Med., 1993, 22, 354–357.
M. Wilson, T. Burns, J. Prattent and G. Pearson, Bacteria in supragingival plaque samples can be killed by low-power laser light in the presnece of a photosensitizer, J. Appl. Bacteriol., 1995, 78, 569–574.
M. Wilson and C. Yanni, Killing of methicillin-resistant staphylococcus aureus by low-power laser light, J. Med. Microbiol., 1995, 42, 62–66.
J. L. Williams, J. Stamp, R. Devonshire and G. J. Fowler, Methylene blue and the photodynamic therapy of superficial bladder cancer, J. Photochem. Photobiol. B, 1989, 4, 229–232.
G. Fowler, R. Rees and R. Devonshire, The photokilling of bladder carcinoma cells in vitro by phenothiazine dyes, Photochem. Photobiol., 1990, 52, 489–494.
P. Herlin, J. Marnay, J. H. Jacob, J. M. Ollivier and A. M. Mandard, A study of the mechanism of the toluidine blue dye test, Endoscopy, 1983, 15, 4–7.
Y. Eliezri, The toluidine blue test: an aid in the diagnosis and treatment of early squamous cell carcinomas of mucous membranes, Journal of the American Academy of Dermatology, 1988, 18, 1339–1349.
J. B. Epstein, C. Oakley, A. Millner, S. Emerton, E. van der Meij and N. Le, The utility of toluidine blue application as a diagnostic aid in patients previously treated for upper oropharyngeal carcinoma, Oral Surg. Oral Med. Oral Pathol., 1997, 83, 537–547.
I. Martin, C. Kerawala and M. Reed, The application of toluidine blue as a diagnostic adjunct in the detection of epithelial dysplasia, Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endodontics, 1998, 85, 444–446.
R. L. Miller, B. W. Simms and A. R. Gould, Toluidine blue staining for detection of oral premalignant lesions and carcinomas, J. Oral Pathol., 1988, 17, 73–78.
J. Lundgren, J. Olofsson and H. Hellquist, Toluidine blue. An aid in the microlaryngoscopic diagnosis of glottic lesions?, Arch. Otolaryngol., 1979, 105, 169–174.
M. S. Strong, C. W. Vaughan and J. Incze, Toluidine blue in diagnosis of cancer of the larynx, Arch. Otolaryngol., 1970, 91, 515–519.
J. Tarkkanen, M. Paavolainen and E. Saksela, Toluidine blue staining in the endoscopic diagnosis of carcinoma of the bronchus, Ann. Clin. Res., 1972, 4, 7–9.
K. A. Warnakulasuriya and N. W. Johnson, Sensitivity and specificity of OraScan (R) toluidine blue mouthrinse in the detection of oral cancer and precancer, J. Oral Pathol. Med., 1996, 25, 97–103.
A. Mashberg, Reevaluation of toluidine blue application as a diagnostic adjunct in the detection of asymptomatic oral squamous carcinoma: a continuing prospective study of oral cancer III, Cancer, 1980, 46, 758–763.
A. McHale and L. McHale, Use of tetrazolium-based colorimetric assay for assessing photoradiation therapy in vitro, Cancer Lett., 1988, 41, 315–321.
R. Bertrand and Y. Pommier, in Cell growth and apoptosis; A practical approach. ed. G. P. Studzinski, IRL Press, New York, 1995, pp. 97–118.
R. Bertrand, M. Sarang, J. Jenkin, D. Kerrigan and Y. Pommier, Differential induction of secondary DNA fragmentation by topoisomerase II inhibitors in human tumor cell lines with amplified c-myc expression, Cancer Res., 1991, 51, 6280–6285.
A. T. Sane and R. Bertrand, Distinct steps in DNA fragmentation pathway during camptothecin-induced apoptosis involved caspase-, benzyloxycarbonyl- and N-tosyl-L-phenylalanylchloromethyl ketone-sensitive activities, Cancer Res., 1998, 58, 3066–3072.
M. Garcia-Calvo, E. P. Peterson, D. M. Rasper, J. P. Vaillancourt, R. Zamboni, D. W. Nicholson and N. A. Thornberry, Purification and catalytic properties of human caspase family members, Cell Death Differ., 1999, 6, 362–369.
M. Wainwright, Non-porphyrin photosensitizers in biomedicine, Chem. Soc. Rev., 1996, 2, 351–358.
Z. Darzynkiewicz and S. P. Carter, Photosensitizing effects of the tricyclic heteroaromatic cationic dyes pyronin Y and toluidine blue O (tolonium chloride), Cancer Res., 1988, 48, 1295–1299.
N. S. Soukos, M. Wilson, T. Burns and P. M. Speight, Photodynamic effects of toluidine blue on human oral keratinocytes and fibroblasts and Streptococcus sanguis evaluated in vitro, Lasers Surg. Med., 1996, 18, 253–259.
F. Gad, G. Viau, M. Boushira, R. Bertrand and R. Bissonnette, Photodynamic therapy with 5-aminolevulinic acid induces apoptosis and caspase activation in malignant T cells, Journal of Cutaneous Medicine and Surgery, 2001, 5, 8–13
M. Dellinger, Apoptosis or necrosis following Photofrin photosensitization: influence of the incubation protocol, Photochem. Photobiol., 1996, 64, 182–187.
Y. Miyamoto, Y. Umebayashi and T. Nishisaka, Comparison of phototoxicity mechanism between pulsed and continuous wave irradiation in photodynamic therapy, J. Photochem. Photobiol. B, 1999, 53, 53–59.
D. Kessel, Y. Luo, Y. Deng and C. K. Chang, The role of subcellular localization in initiation of apoptosis by photodynamic therapy, Photochem. Photobiol., 1997, 65, 422–426.
S. R. Wood, J. A. Holroyd and S. B. Brown, The subcellular localization of Zn(II) phthalocyanines and their redistribution on exposure to light, Photochem. Photobiol., 1997, 65, 397–402.
N. S. Trivedi, H. W. Wang, A. L. Nieminen, N. L. Oleinick and J. A. Izatt, Quantitative analysis of Pc 4 localization in mouse lymphoma (LY-R) cells via double-label confocal fluorescence microscopy, Photochem. Photobiol., 2000, 71, 634–639.
G. G. Miller, K. Brown, A. M. Ballangrud, O. Barajas, Z. Xiao, J. Tulip, J. W. Lown, J. M. Leithoff, M. J. Allalunis-Turner, R. D. Mehta and R. B. Moore, Preclinical assessment of hypocrellin B and hypocrellin B derivatives as sensitizers for photodynamic therapy of cancer: progress update, Photochem. Photobiol., 1997, 65, 714–722.
A. J. Dunipace, R. Beaven, T. Noblitt, Y. Li, S. Zunt and G. Stookey, Mutagenic potential of toluidine blue evaluated in the Ames test, Mutat. Res., 1992, 279, 255–259.
J. Y. Matroule, C. M. Carthy, D. J. Granville, O. Jolois, D. W. Hunt and J. Piette, Mechanism of colon cancer cell apoptosis mediated by pyropheophorbide-a methyl ester photosensitization, Oncogene, 2001, 20, 4070–4084.
W. L. Rumboltz, C. F. Moon, J. C. Novelli and A. B. Omaha, Use of protamine sulfate and toluidine blue for abnormal uterine bleeding, Am. J. Obstet. Gynecol., 1952, 63, 1029–1037.
C. A. Lathrop and W. T. Carlisle, Oral toluidine blue in the treatment of hypermenorrhea, Am. J. Obstet. Gynecol., 1952, 64, 1376–1377.
W. Bickers, Toluidine blue-An evaluation in the treatment of uterine bleeding, Am. J. Obstet. Gynecol., 1953, 66, 1313–1317.
R. J. Hurvitz, S. L. Perzik and L. Morgenstern, In vivo staining of the parathyroid glands. A clinical study, Arch. Surg., 1968, 97, 722–726.
R. M. Yeager and E. T. Krementz, Toluidine blue in identification of parathyroid glands at operation, Ann. Surg. (Chicago), 1969, 169, 829–838.
R. E. Moe and P. J. Klopper, Demonstration of the functional anatomy of the canine gastric antrum. II. Operative technics not requiring gastrotomy, Am. J. Surg., 1966, 111, 80–88.
Acknowledgements
We would like to acknowledge advice and suggestions provided by Dr Richard Bertrand. This work was funded by the University of Montreal Hospital Center Foundation.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tremblay, JF., Dussault, S., Viau, G. et al. Photodynamic therapy with toluidine blue in Jurkat cells: cytotoxicity, subcellular localization and apoptosis induction. Photochem Photobiol Sci 1, 852–856 (2002). https://doi.org/10.1039/b204385h
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1039/b204385h